ATE494909T1 - Zusammensetzungen mit antigen-komplexen,verfahren zu ihrer herstellung und verfahren zur verwendung derantigen-komplexe zur vakzinierung - Google Patents
Zusammensetzungen mit antigen-komplexen,verfahren zu ihrer herstellung und verfahren zur verwendung derantigen-komplexe zur vakzinierungInfo
- Publication number
- ATE494909T1 ATE494909T1 AT03811387T AT03811387T ATE494909T1 AT E494909 T1 ATE494909 T1 AT E494909T1 AT 03811387 T AT03811387 T AT 03811387T AT 03811387 T AT03811387 T AT 03811387T AT E494909 T1 ATE494909 T1 AT E494909T1
- Authority
- AT
- Austria
- Prior art keywords
- antigen complexes
- vaccination
- production
- compositions containing
- antigens
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title abstract 4
- 102000036639 antigens Human genes 0.000 title abstract 4
- 108091007433 antigens Proteins 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title 1
- 238000002255 vaccination Methods 0.000 title 1
- 108010052285 Membrane Proteins Proteins 0.000 abstract 2
- 102000018697 Membrane Proteins Human genes 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 241000700605 Viruses Species 0.000 abstract 1
- 239000002671 adjuvant Substances 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000002209 hydrophobic effect Effects 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 239000012678 infectious agent Substances 0.000 abstract 1
- 230000003993 interaction Effects 0.000 abstract 1
- 239000000693 micelle Substances 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1275—Lipoproteins or protein-free species thereof, e.g. chylomicrons; Artificial high-density lipoproteins [HDL], low-density lipoproteins [LDL] or very-low-density lipoproteins [VLDL]; Precursors thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Otolaryngology (AREA)
- Virology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02102610 | 2002-11-20 | ||
| EP0350638 | 2003-09-18 | ||
| PCT/EP2003/013084 WO2004045641A2 (en) | 2002-11-20 | 2003-11-20 | Antigen-complexes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE494909T1 true ATE494909T1 (de) | 2011-01-15 |
Family
ID=34379291
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03811387T ATE494909T1 (de) | 2002-11-20 | 2003-11-20 | Zusammensetzungen mit antigen-komplexen,verfahren zu ihrer herstellung und verfahren zur verwendung derantigen-komplexe zur vakzinierung |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1578443B1 (de) |
| AT (1) | ATE494909T1 (de) |
| AU (1) | AU2003296592A1 (de) |
| DE (1) | DE60335742D1 (de) |
| WO (1) | WO2004045641A2 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7491395B2 (en) | 2002-11-20 | 2009-02-17 | Bestewil Holding B.V. | Compositions comprising antigen-complexes, method of making same as well as methods of using the antigen-complexes for vaccination |
| TWI329130B (en) * | 2003-06-19 | 2010-08-21 | Bestewil Holding Bv | Functionally reconstituted viral membranes containing adjuvant |
| EP2549990A1 (de) * | 2010-03-23 | 2013-01-30 | Irm Llc | Verbindungen (cysteinbasierte lipopeptide) und zusammensetzungen als tlr2-agonisten zur behandlung von infektionen, entzündungen, atemwegserkrankungen etc. |
| DK3728287T3 (da) * | 2017-12-19 | 2024-06-10 | CSL Behring Lengnau AG | Proteinoprensning og virusinaktivering med alkylglycosider |
| CN117147882B (zh) * | 2023-10-31 | 2024-01-26 | 中国农业科学院生物技术研究所 | 抗虫蛋白Cry 1Ah酶联免疫定量检测试剂盒及方法 |
| CN119552272A (zh) * | 2025-01-21 | 2025-03-04 | 北京华诺泰生物医药科技有限公司 | 一种水痘-带状疱疹病毒gE融合蛋白、制备方法及其应用 |
| CN119925588B (zh) * | 2025-04-08 | 2025-07-01 | 北京华诺泰生物医药科技有限公司 | 基于gE/pORF7双抗原纳米晶与智能相变佐剂的重组带状疱疹疫苗 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8205892D0 (sv) | 1982-10-18 | 1982-10-18 | Bror Morein | Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin |
| SE8405493D0 (sv) | 1984-11-01 | 1984-11-01 | Bror Morein | Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel |
| EP0231039B1 (de) * | 1986-01-14 | 1992-01-08 | De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur | Verfahren zur Herstellung immunologischer Komplexe und diese enthaltende pharmazeutische Zusammensetzung |
| NZ224422A (en) | 1987-05-05 | 1990-11-27 | Molecular Eng Ass | Composition adapted for intranasal immunisation against viral infection comprising a glycoprotein complexed with a lipid |
| CA2086831C (en) | 1991-05-08 | 1999-03-16 | Reinhard Gluck | Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them |
| US5936076A (en) | 1991-08-29 | 1999-08-10 | Kirin Beer Kabushiki Kaisha | αgalactosylceramide derivatives |
| FR2771640B1 (fr) * | 1997-12-03 | 2000-02-11 | Inst Nat Sante Rech Med | Micelles mixtes de lipopeptides pour l'induction d'une reponse immunitaire et leurs utilisations a des fins therapeutiques |
| US6733985B1 (en) * | 1999-05-19 | 2004-05-11 | International Technidyne Corporation | Preparation of stable liquid and dried synthetic prothrombin time reagents |
| WO2001060402A2 (en) * | 2000-02-15 | 2001-08-23 | Intellivax International Inc. | Proteosome influenza vaccine |
| US6338859B1 (en) * | 2000-06-29 | 2002-01-15 | Labopharm Inc. | Polymeric micelle compositions |
-
2003
- 2003-11-20 AT AT03811387T patent/ATE494909T1/de active
- 2003-11-20 WO PCT/EP2003/013084 patent/WO2004045641A2/en not_active Ceased
- 2003-11-20 EP EP03811387A patent/EP1578443B1/de not_active Expired - Lifetime
- 2003-11-20 DE DE60335742T patent/DE60335742D1/de not_active Expired - Lifetime
- 2003-11-20 AU AU2003296592A patent/AU2003296592A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004045641A3 (en) | 2005-02-03 |
| EP1578443B1 (de) | 2011-01-12 |
| WO2004045641A2 (en) | 2004-06-03 |
| AU2003296592A8 (en) | 2004-06-15 |
| AU2003296592A1 (en) | 2004-06-15 |
| DE60335742D1 (de) | 2011-02-24 |
| EP1578443A2 (de) | 2005-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bergmann-Leitner et al. | Adjuvants in the driver’s seat: how magnitude, type, fine specificity and longevity of immune responses are driven by distinct classes of immune potentiators | |
| CY1122505T1 (el) | Anti-il-12 αντισωματα, συνθεσεις, μεθοδοι και χρησεις για την θεραπευτικη αγωγη της παθολογιας του crohn | |
| RU2009144125A (ru) | Виросомы, содержащие гемагглютинин, полученный из вируса гриппа, вырабатываемого в клеточной линии; композиции, методы получения и применение на их основе | |
| EP1917033A4 (de) | Virusähnliche partikel als paramyxovirus-impfstoffe | |
| IL150602A0 (en) | Proteosome influenza vaccine | |
| EP1584685A3 (de) | Tumorassoziierte Antigenderivate der Mage-Familie, Nukleinsäuresequenzen, die dafür kodieren, zur Herstellung von Fusionsproteinen und Zusammensetzungen zur Impfung | |
| UA93855C2 (ru) | Вакцина, способствует росту, базирующейся ha нейтрализующем эпитопе | |
| DE60117164D1 (de) | Impfstoffe mit erhöhter immunantwort und verfahren zur deren herstellung | |
| WO2005037190A3 (en) | Multiplex vaccines | |
| WO2004098533A3 (en) | Vectors and cells for preparing immunoprotective compositions derived from transgenic plants | |
| EP2368576A3 (de) | Funktionell neu errichtete Virenmembranen mit Adjuvantien | |
| DE602005025342D1 (de) | Impfstoffzusammensetzungen mit virosomen und einem saponin-adjuvans | |
| WO2004026265A3 (en) | Compositions and methods for treatment of herpesvirus infections | |
| WO2005007673A3 (en) | Immunogenic peptides | |
| NO20090177L (no) | Vaksiner for malaria | |
| Martelet et al. | Porcine dendritic cells as an in vitro model to assess the immunological behaviour of Streptococcus suis subunit vaccine formulations and the polarizing effect of adjuvants | |
| WO2008118487A3 (en) | Compositions and methods for incresing immunogenicity of glycoprotein vaccines | |
| ATE494909T1 (de) | Zusammensetzungen mit antigen-komplexen,verfahren zu ihrer herstellung und verfahren zur verwendung derantigen-komplexe zur vakzinierung | |
| JP7016317B2 (ja) | アジュバント組成物 | |
| WO2024047091A3 (en) | Veterinary compositions of modified virus-like particles of cmv and ngf antigens | |
| WO2002053588A3 (en) | Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of chlamydia psittaci | |
| ATE500848T1 (de) | Verfahren zur herstellung eines stabilen immunogenen produkts beinhaltend antigene- heterokomplexe aus tnf-aplha und einem trägerprotein | |
| ATE505482T1 (de) | Impfstoff gegen infektiöses lachsanämievirus | |
| WO2002036160A3 (es) | Método de obtención de estructuras antigénicas que potencian la reactividad cruzada específica | |
| Kahraman et al. | A novel trivalent inactivated Salmonella vaccine formulated with CpG ODNs to enhance the cellular immunity in chickens |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1578443 Country of ref document: EP |